Ceftazidime 1 g / 1 Injection 25 Vial, Patent Delivery System (Tazicef)
Comprehensive product details for sourcing and verification.
| NDC 11 | 00409-5092-16 |
|---|---|
| Product NDC | 00409-5092 |
| Generic Drug Name | Ceftazidime |
| Brand Name | Tazicef |
| Manufacturer | Hospira, Inc. |
| Strength | 1 g / 1 |
| Dosage Form | Injection |
| Drug Type | Intravenous |
| Package Quantity | 25 Vial, Patent Delivery System |
| Package Description | 25 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-5092-16) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (0409-5092-11) |
| Active Ingredients | Ceftazidime |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Ceftazidime 1 g / 1 Injection is tracked under NDC 00409-5092-16 and rolls up into product family 00409-5092. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 25 Vial, Patent Delivery System.
- Manufacturer: Hospira, Inc..
- Dosage form: Injection.
- Family size: 1 active presentation.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Drug Shortage Information
Drug Shortage Index family
View Ceftazidime in the Drug Shortage IndexCompare related exact NDC products and family-level shortage context for Ceftazidime.Source: Public FDA drug shortage records accessed through FDA-owned openFDA drug shortages queries.
This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Ceftazidime 1 g / 1 Injection 25 Vial, Patent Delivery System (Tazicef), NDC 00409-5092-16, is a Hospira, Inc. 1 g / 1 injection presentation packaged as 25 Vial, Patent Delivery System. Historical public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 00409-5092-16.
- Digits-only NDC 11: 00409509216.
- Possible 10-digit display format: 0409-5092-16 (0409509216).
Helpful product links
- Search by brand name: Tazicef.
- Exact NDC 11: 00409-5092-16.
- Product family NDC: 00409-5092.
Related shortage research
If your team is researching the broader shortage picture, the family page groups related exact NDC items, brand variations, and family-level shortage context in one place.